Jasper Therapeutics Inc (NAS:JSPR)
$ 22.5 0.38 (1.72%) Market Cap: 339.42 Mil Enterprise Value: 218.22 Mil PE Ratio: 0 PB Ratio: 3.00 GF Score: 23/100

Jasper Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 07, 2023 / 05:00PM GMT
Release Date Price: $16 (+1.91%)
Ronald Martell
Jasper Therapeutics, Inc. - CEO

Good morning, ladies and gentlemen. Welcome to the 2023 annual meeting of stockholders of Jasper Therapeutics, Inc. I am Ronald Martell, the company's Chief Executive Officer and President. At this time, I call the meeting to order.

I'm pleased to conduct our meeting virtually via the Internet. The company's Board of Directors has appointed me to act as Chairman of this meeting. Jeet Mahal, the company's Chief Operating and Chief Financial Officer, will act as Secretary of this meeting.

I would also like to introduce Jeff Zechnich, a partner at PricewaterhouseCoopers LLP, our independent registered public accounting firm. During the question-and-answer period at the end of today's session, Mr. Zechnich will be available to answer any appropriate questions you may have concerning the independent audit.

The Board of Directors has appointed Henry Farrell of Continental Stock Transfer & Trust Company to act as Inspector of Elections for this meeting. Mr. Farrell has previously taken his oath as Inspector of Elections. We will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot